Medical Cannabis and Cannabinoids:

policy, science,
and medical practice

Prague / 4–7 March / 2015

Konference je akreditována v systémech celoživotního vzdělávání ČLK, ČLnK a ČAS

Conference Programme

You can watch all presentations online here.

Final programme as of 06.03.2015. Conference languages: English and Czech (with translation). Credits: Camera Medica Bohemica 18 credits (event no 38620); Czech Chamber of Pharmacists 20 points (event no 15297). Czech Association of Nurses 12 credits (event no ČAS/KK/365/2015).


Day 1:

Is there enough space for lege artis medicine and advanced research within the UN conventions?

8.00-17.00           On-site registration (Marriott Hotel foyer)

9.30-11.00           Launch of the conference (Bohemia II+III)

Introductory speeches of honorary guests

Chair:

Dr. Tomáš Zábranský (Czech Republic)

Speakers:

Pavel Bém, president of the conference

Dr. Svatopluk Němeček, Minister of Health of the Czech Republic, patron of the conference

Prof. Jan Žaloudík, member of the Senate of the Parliament of the Czech Republic

Prof. Michel Kazatchkine, The Global Commission on Drug Policy

Jindřich Vobořil MA MHA, the Czech National Drug Coordinator

Prof. Tomáš Zima, Rector of Charles University in Prague, chair of the Honorary Board of the Conference 

Prof. Raphael Mechoulam, rector emeritus, Hebrew University of Jerusalem

 

11.00     Press conference

(media only - late accreditation on media@resad.cz and at the conference reception)

 

11.20-11.50        Plenary discussion organised under the auspices of the Global Commission on Drug Policy (GCoDP) (Bohemia II+III)

Medical Marijuana vs. Devil’s Weed, Relieving Morphine vs. Smack, Ritalin for our Kids and Meth Definitely Not For Our Kids: what regulation for what – and why?

Moderator:

Pavel Bém (Czech Republic); The options for legal regulation of drug markets

Speakers:

Prof. Michel Kazatchkine (France):  Supranational legislature / UN Convention and the level of freedom of individual states for securing necessary controlled medicines to patients.

Steph Sherer (USA): The US federal and national legislature on medical marijuana, and controlled drugs in general: a pitfall or a space for maneuvring?

Dr. Pavel Pachta (ex-INCB secretariat): The international drug control treaties and medical use of cannabis and cannabinoids - INCB approach in time

Milton Romani Gerner (Uruguay): Uruguay and its legislature on medical and recreational cannabis: state of art and outlook

Dr. Eberhard Pirich (Austria): The Austrian model of prescription and reimbursement of cannabinoids

 

14.00-15.15        Parallel sessions

1) Policy in medical cannabis and other psychoactive substances – the EU experience (Bohemia II+III)

Moderator:

Danillo Ballotta (European Monitoring Centre for Drugs and Drug Addictions – EMCDDA)

Rapporteur:

Jindřich Vobořil (Czech National Drug Coordinator)

 

2) Policy in medical cannabis and other psychoactive substances – the Canadian experience (Moravia II)

Moderator:

Prof. Philippe Lucas (Canada)

Rapporteur:

Dr. Hanan Abramovici (Canada)


15.30-16.45        Parallel sessions

1) Policy in medical cannabis and other psychoactive substances – the Latin American experience (Moravia II)

Moderator:

Dr. Julio Calzada Mazzei (Uruguay)

Rapporteur:

TBA

2) Policy in medical cannabis and other psychoactive substances – the US experience (Bohemia II+III)

Moderator:

Steph Sherer (USA)

Rapporteur:

Dr. Jahan Marcu (USA)   

 

17.00-18.30        Plenary discussion: Medical cannabis reform in multiple legal and medical environments (Bohemia II+III)

Medical cannabis reform in multiple legal and medical environments – different approaches, different proceedings, one goal (rapporteurs from the parallel sessions, followed by roundtable discussion with a moderator)

Moderator:

Dr. Vendula Běláčková (Czech Republic); Brief overview of the long story of medical cannabis in the Czech Republic

Speakers:

Jindřich Vobořil (CZ), Prof. Philippe Lucas (USA), Dr. Jahan Marcu (USA), Dr. Julio Calzada Mazzei (Uruguay)

 

19.00-21.00        Conference Banquet (by invitation only/application at registration necessary)

 


Day 2:

What to do with medical cannabis, why to do it and how?

 

9.00-10.30           PLENARY: Cannabis and cannabinoids in medical research and medical treatment  (Moravia I + II + III)

Overview of cannabis and cannabinoids in medical research and medical treatment. The state of research in the area of medical cannabis and its prospects.

Chair:

Prof. Raphael Mechoulam (Israel)

Discussants:

Dr. Yuval Landschaft (Israel): Research nd medical cannabis in the State of Israel

Dr. Arno Hazekamp (Netherlands):  Standardisation of CBD and THC-CBD delivery by vaporisation - protocolas and options

Prof. Ethan Russo (USA): A Researcher's View on Practical Aspects and Pitfalls of Treatment with Medical Cannabis

Prof. Raphael Mechoulam (Israel): Discussion overview and personal insight

 

10.50-12.20        Joint medical workshop (all specializations): Introduction into practical use of cannabis for medical doctors and nurses - part I (Moravia I + II + III)

The human endocannabinoid system and the treatment of medical symptoms. Medical cannabis and indications for medical use in Israel and elsewhere.

Moderators/trainers:

Dr. Yehuda Baruch (Israel - OWC), Zach Klein, Yelena Sosnovsky, DiS MedNurse (Israel)

13.50-15.20        Joint medical workshop (all specializations): Introduction into practical use of cannabis form medical doctors and nurses - part II (Moravia I + II + III)

Synthetic endocannabinoids: harms and medical use. Most frequent side-effects of (medical) cannabis use and how to treat them

Moderators/trainers:

Dr. Yehuda Baruch (Israel - OWC), Zach Klein, Yelena Sosnovsky, DiS MedNurse (Israel)

 

15.45-17.15        Joint medical workshop (all specializations): Introduction into practical use of cannabis form medical doctors and nurses - part III (Moravia I + II + III) 

Various strains of medical cannabis and when to use them. Dosing of medical cannabis (how to start, how long, how and when to stop) – part 1.

Moderators/trainers:

Dr. Yehuda Baruch (Israel - OWC), Zach Klein, Yelena Sosnovsky, DiS MedNurse (Israel)

 

10.30 – 17.15     Closed meeting of patients’ unions for treatment with cannabis and cannabinoids (Valtice)

 


Day 3:

What to do with medical cannabis, why to do it and how?

 

9.00-10.30           PLENARY: Ethical Issues in Treatment and Medical Research Using Medical Cannabis (hosted by better) (Moravia I + II + III)

Moderator:

Pavel Kubů (Czech Republic)

Speakers:

Dr. Sue Sisley (USA), Dr. Ilya Reznik (Israel), Prof. Uri Kramer (Israel), Steph Sherer (USA)

 

10.50-12.45 Joint medical workshop (all specializations): Introduction into practical use of cannabis form medical doctors and nurses - part IV (Moravia I + II + III)


Dosing of medical cannabis (how to start, how long, how and when to stop) – part 2. Various ways of consumption and related equipment. Role of physicians/ role of nurses; telephone helplines and other support. Technical Guidelines for prescribing medical cannabis and preparations made of it in the Czech Republic (Czech State Agency for Medical Cannabis).

Moderators/trainers:

Dr. Yehuda Baruch (Israel - OWC) and Jana Venclíková (Czech Republic)

  

13.45-14.45        Parallel Medical workshops

1) Pain management using cannabinoids (Moravia I)

Trainer:

Prof. Silviu Brill (Israel) 

2) Medical cannabis in palliative care (Moravia II)

Trainer:

Dr. Jonathan Grunfeld (Israel) - hosted by better

3) Cannabis and cannabinoids in neurology and dermatology (Moravia III)

Trainer:

Dr. Támás Biró (Hungary) 

 

15.05-16.40        Parallel Medical Workshops         

1) Medical cannabis in oncology (Moravia I)

Trainer:

Dr. Jonathan Grunfeld (Israel) – hosted by better

2) PTSD, Tourette sydrome and other psychiatric diagnoses for cannabis use (Moravia II)

Trainer:

Dr. Sue Sisley (USA) – hosted by better

3) Cannabis and epilepsy in children and adolescents – the situation in Israel, USA, and elsewhere (Moravia III)

Trainer:

Prof. Uri Kramer (Israel) – hosted by better

4) Cannabis and cannabinoids in dermatology - PROGRAMME CHANGE

Cannabis and cannabinoids in dermatology will be one of the subjects of the workshop at 13:45.

 

10.30-15.15        Closed meeting of patients’ unions for treatment with cannabis and cannabinoids (Valtice)

 


Day 4:

What the science knows and it would like to know?

 

9.00-10.30           PLENARY: The advances and future directions in cannabis and cannabinoids research (Bohemia II)

The use of cannabis and cannabinoids in modern medical practice. The cutting-edge research and scientific prospects in the area of medical cannabis.

Moderator and rapporteur:

Prof. Lumír Hanuš (Czech Republic and Israel)

Speakers:

Prof. Pal Pacher (USA): Key opposing regulatory role of peripheral cannabinoid CB1 and CB2 receptors in inflammatory processes, oxidative stress and tissue injury

Prof. Uri Kramer (Israel): Cannabidiol for children with refractory epilepsy - The Israeli experience

Prof. Ethan Russo (Israel): Researchers view on practical aspects of treatment with medical cannabis and phytocannabinoids

Prof. Silviu Brill (Israel): Pain, cannabis and cannabinoids: mechanisms, use and future directions

 

10.50-12.20        Parallel sessions

1) Cannabinoid research in the Czech Republic – Brno team (Bohemia II + III)

Moderator:

Prof. Alexandra Šulcová (Czech Republic): "Moravian" contributions for the identification of endocannabinoid system

Presenters and discussants:

Dr. Vincenzo Micale (Italy): The endogenous cannabinoid system (ECS) as a potential therapeutic target in schizophrenia: preclinical and clinical evidence  

Dr. Jana Kučerová (Czech Republic): The cannabis and cannabinoid "self-medication" theory: animal depressive phenotype model 

Dr. Jan Juřica (Czech Republic):  The influence of the cannabinoids on the activity of the metabolic enzymes P450 cytochrome

 

2) Session II - cancelled

  

13.45-14.45        PLENARY: Cannabis, cannabinoids (and alternatives) for the wellbeing of patients (Bohemia II)

Moderator:

Prof. Richard Rokyta (Czech Republic)

Speakers:

Dr. Arno Hazekamp (Netherlands): What the patients really want - the dosage and the ways of use, globally

Prof. Cristina Sanchéz (Spain): Endocannabinoids, Phytocannabinoids, and Cancer

Prof. David Meiri (Israel): Cannabinoids antitumor activity in humnan cancers

Dr. Mark J. Rosenfeld (USA/Canada/Israel/China): Making Cannabinoids Legal & Effective, Science-Based Medicine

15.05-16.50        Parallel sessions

1) Cannabis extract - case studies and practical experiences of natural healers (Bohemia II)

Moderator:

prof. Lumír Hanuš  (Czech Republic and Israel)

Presenters and discussants:

Jindřich Bayer (Czech Republic)
Ted Hong (South Korea)
Dušan Dvořák (Czech Republic)
Bozidar Radisic (Slovenia)
Patryck Pankowski (Poland)
Lukáš Hurt (Czech Republic)
Andrej Susnik (Slovenia)

2) Pitfalls and obstacles: potential side-effects of medical cannabis and cannabinoids in treatment (Czech Addiction Society) (Hluboká I)

Speakers and moderator:

TBA by Czech Addiction Society of J.E. Purkyne

 

16.50 Closure of the conference

  


 

Posters in the conference foyer

- during all four days; poster session always from 14.45-15.45:

Jakub Šmíd (Czech Republic): The development of medical cannabis varieties

Michael Krawitz (USA): Medical Cannabis, human rights and medical ethics

Pavlína Pamánková, Petra Mikšátková, Michael Roman, Martin Kuchař (Czech Republic): Analysis of cannabinoids in wild Cannabis plants from South Moravia